These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2866167)

  • 21. [Ototoxicity and nephrotoxicity of netilmicin and other aminoglycoside antibiotics in rabbits].
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1982 Apr; 85(4):447-54. PubMed ID: 7119929
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
    Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin and sisomicin - induced renal tubular damage.
    Nicot G; Merle L; Valette JP; Charmes JP; Lachâtre G
    Eur J Clin Pharmacol; 1982; 23(2):161-6. PubMed ID: 6128232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    de Jager P; van Altena R
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.
    Nordström L; Christensson P; Haeger K; Juhlin I; Tjernström O; Wallmark E
    J Int Med Res; 1979; 7(2):117-26. PubMed ID: 478159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sisomicin in the treatment of severe or complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1978 Feb; 87(605):91-4. PubMed ID: 273804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cisplatin nephrotoxicity: effects on fractional excretion of sodium and enzymuria].
    Cirami C; Bianchi AM; Galigani P; Gadducci A; Colombi L; Facchini V; Palla R
    Minerva Med; 1990; 81(1-2):79-86. PubMed ID: 1969127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary phospholipids excretion in neonates treated with amikacin.
    Ibrahim S; Langhendries JP; Bernard A; Tulkens PM
    Int J Clin Pharmacol Res; 1994; 14(5-6):149-56. PubMed ID: 7672871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary sediment bacteriuria and enzymuria in the early diagnosis and prevention of pyelonephritis].
    Campanacci L; Guarnieri GF; Faccini L; Carretta R; Monsacchi P; Chersicla M; Galli G; Guerrini D
    G Clin Med; 1978 Dec; 59(72):544-68. PubMed ID: 378742
    [No Abstract]   [Full Text] [Related]  

  • 33. Amikacin pharmacokinetics in the therapy of childhood urinary tract infection.
    Khan AJ; Evans HE; Jhaveri R; Chang CT; Hochstein L
    Pediatrics; 1976 Dec; 58(6):873-6. PubMed ID: 995517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].
    Naumann P; Rosin H
    Adv Clin Pharmacol; 1978; 15():23-34. PubMed ID: 676876
    [No Abstract]   [Full Text] [Related]  

  • 37. [Netilmicin in refractory urinary tract infections. Good therapeutic effect in spite of long dosage intervals].
    Brunner FP; Wenk M; Mauracher E; Thiel G; Follath F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):934-41. PubMed ID: 7112061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of therapeutic gentamycin doses on the enzyme secretion in urine].
    Burchardt U; Peters JE; Gründig CA
    Z Gesamte Inn Med; 1975 Apr; 30(7):265-8. PubMed ID: 856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
    Fillastre JP; Hemet J; Tulkens P; Morin JP; Viotte G; Olier B; Godin M
    Adv Nephrol Necker Hosp; 1983; 12():253-75. PubMed ID: 6404138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lithium and the kidney. Acute effects on ADH secretion and enzymuria].
    Palla R; Galigani P; Marchitiello M; Tuoni M; Lenzi A; Placidi GF
    Minerva Med; 1986 Feb; 77(7-8):205-8. PubMed ID: 2869450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.